Charles River Laboratories International, Inc. (CRL): Price and Financial Metrics


Charles River Laboratories International, Inc. (CRL)

Today's Latest Price: $136.12 USD

3.31 (2.49%)

Updated Apr 7 9:41am

Add CRL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

CRL Stock Summary

  • CRL has a market capitalization of $5,391,428,509 -- more than approximately 82.73% of US stocks.
  • CRL's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 402.5 -- higher than 92.61% of US-listed equities with positive expected earnings growth.
  • In terms of volatility of its share price, CRL is more volatile than only 19.29% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Charles River Laboratories International Inc, a group of peers worth examining would be PRAH, HURN, EXLS, FDS, and G.
  • CRL's SEC filings can be seen here. And to visit Charles River Laboratories International Inc's official web site, go to www.criver.com.
CRL Daily Price Range
CRL 52-Week Price Range

CRL Stock Price Chart More Charts


CRL Price/Volume Stats

Current price $136.12 52-week high $179.38
Prev. close $132.81 52-week low $95.58
Day low $135.68 Volume 9,665
Day high $137.92 Avg. volume 473,181
50-day MA $145.24 Dividend yield N/A
200-day MA $140.30 Market Cap 6.74B

Charles River Laboratories International, Inc. (CRL) Company Bio


Charles River Laboratories provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company was founded in 1947 and is based in Wilmington, Massachusetts.

CRL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$136.12$131.65-1%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Charles River Laboratories International Inc. To summarize, we found that Charles River Laboratories International Inc ranked in the 40th percentile in terms of potential gain offered. The most interesting components of our discounted cash flow analysis for Charles River Laboratories International Inc ended up being:

  • 77% of the company's capital comes from equity, which is greater than 60.11% of stocks in our cash flow based forecasting set.
  • The weighted average cost of capital for the company is 7. This value is greater than merely 12.07% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-3%
1%-2%
2%-1%
3%0%
4%1%
5%2%

Want more companies with a valuation profile/forecast similar to that of Charles River Laboratories International Inc? See ARNA, GILD, MD, PDLI, and DXCM.


CRL Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CRL Latest Social Stream


Loading social stream, please wait...

View Full CRL Social Stream

CRL Price Returns

1-mo -12.23%
3-mo -12.14%
6-mo 4.06%
1-year -6.00%
3-year 55.58%
5-year 72.22%
YTD -10.89%
2019 34.97%
2018 3.41%
2017 43.65%
2016 -5.22%
2015 26.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8646 seconds.